FDA recall record

Konsyl Pharmaceuticals PSYLLIUM FIBER, Laxative/Supplement, 100 Capsules, OTC recall — FDA D-1315-2014

Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.

Class IIIclassification
D-1315-2014official record ID
May 21, 2014report date

Recall record at a glance

Official recordD-1315-2014
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmKonsyl Pharmaceuticals Inc.
Report dateMay 21, 2014
Recall initiation dateApr 1, 2014
Quantity6286 Bottles
LocationEaston, MD, United States

Official product description

PSYLLIUM FIBER, Laxative/Supplement, 100 Capsules, OTC. Manufactured By: Konsyl Pharmaceuticals, Inc., Easton, MD 21601. NDC: 0224-1847-10.

Why the product was recalled

Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.

Distribution information

USA including FL, MN, NY, OH, OR, PA, TX, SC and Puerto Rico; Dominican Republic.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.